FDA Inspection
Eurofins PROXY Laboratories B.V.Eurofins PROXY Laboratories B.V. – FDA Inspection, Sep 7, 2017
Record Details
This FDA Inspection record concerns Eurofins PROXY Laboratories B.V., with an inspection on September 7, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3ae54340-2ba7-474f-81da-56b1b9577a76
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1028845
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Eurofins PROXY Laboratories B.V.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 19, 2025 | Not classified | Office of Inspections and Investigations | Blood and Blood Products |
| July 1, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 21, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 15, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Eurofins PROXY Laboratories B.V.
- FDA Inspection 1282304 - 2025-09-19
- FDA Inspection 1272171 - 2022-07-01
- FDA Inspection 1124234 - 2019-08-21
- FDA Inspection 904889 - 2014-11-06
- FDA Inspection 750139 - 2011-09-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.